Atlas Trials

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Clinical trial NCT05204550 · COMPLETED

Trial details

NCT number
NCT05204550
Sponsor
Murdoch Childrens Research Institute
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2023-01-30
Primary completion
2024-12-09
Enrollment
506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.